The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share. The biotechnology company posted revenue of $164.9 million in the period, which topped ...

Ultragenyx (RARE) delivered earnings and revenue surprises of -12.10% and 1.01%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

The biotech’s candidate is MET-224o, an ultra-long acting GLP-1 receptor agonist ... chronic kidney disease based on finding that loss-of-function variants in SLC6A19 were associated with ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to ...

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D ...

Shares of Rezolute RZLT have rallied 30.8% in the past six months against the industry’s decline of 4.1%, driven by investor ...

RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines to send his nomination to the full chamber.

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

Nissan and Honda ended merger talks to forge a $60 billion car company on Thursday, pitching Nissan deeper into uncertainty ...

Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...